Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

VEZT Protein (Myc-DYKDDDDK Tag)

VEZT Origine: Humain Hôte: HEK-293 Cells Recombinant > 80 % as determined by SDS-PAGE and Coomassie blue staining AbP, STD
N° du produit ABIN2735249
  • Antigène Tous les produits VEZT
    VEZT (Vezatin, Adherens Junctions Transmembrane Protein (VEZT))
    Type de proteíne
    Recombinant
    Origine
    Humain
    Source
    • 1
    HEK-293 Cells
    Purification/Conjugué
    Cette VEZT protéine est marqué à la Myc-DYKDDDDK Tag.
    Application
    Antibody Production (AbP), Standard (STD)
    Attributs du produit
    • Recombinant human VEZT (Vezatin) protein expressed in HEK293 cells.
    • Produced with end-sequenced ORF clone
    Pureté
    > 80 % as determined by SDS-PAGE and Coomassie blue staining
  • Indications d'application
    Recombinant human proteins can be used for:
    Native antigens for optimized antibody production
    Positive controls in ELISA and other antibody assays
    Commentaires

    The tag is located at the C-terminal.

    Restrictions
    For Research Use only
  • Concentration
    50 μg/mL
    Buffer
    25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
    Stock
    -80 °C
    Stockage commentaire
    Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
  • Antigène
    VEZT (Vezatin, Adherens Junctions Transmembrane Protein (VEZT))
    Autre désignation
    Vezt (Vezatin) (VEZT Produits)
    Synonymes
    DKFZp469O2222 Protein, VEZATIN Protein, 6330418D12 Protein, AI854408 Protein, vezatin Protein, vezatin, adherens junctions transmembrane protein Protein, vezatin, adherens junctions transmembrane protein L homeolog Protein, VEZT Protein, vezt Protein, Vezt Protein, vezt.L Protein
    Sujet
    This gene encodes a transmembrane protein which has been localized to adherens junctions and shown to bind to myosin VIIA. Examination of expression of this gene in gastric cancer tissues have shown that expression is decreased which appears to be related to hypermethylation of the promoter. Expression of this gene may also be inhibited by binding of a specific microRNA to a target sequence in the 3' UTR of the transcripts. A pseudogene of this gene is located on the X chromosome. Alternative splicing results in multiple transcript variants.
    Poids moléculaire
    88.5 kDa
    NCBI Accession
    NP_060069
Vous êtes ici:
Support technique